Medicare Part D coverage · eltrombopag · RxCUI 1859501
eltrombopag 25 MG Powder for Oral Suspension [Promacta]
Per the CMS 2026 Part D formulary file, eltrombopag 25 MG Powder for Oral Suspension [Promacta] is covered by 1,016 Medicare Part D plans (20.1% of enrollable products), averaging Tier 4.8, with prior authorization required on 100% of covering formularies.
- 20.1%
- Plan coverage
- 1,016
- Plans covering
- T4.8
- Avg tier
- 100%
- Prior auth required
What the CMS Formulary Data Shows for eltrombopag 25 MG Powder for Oral Suspension [Promacta]
Per the CMS 2026 Part D formulary file, eltrombopag 25 MG Powder for Oral Suspension [Promacta] (RxNorm concept RXCUI 1859501, generic name eltrombopag) appears on 22 distinct formulary files spanning 1,016 Medicare Part D plan offerings - 20.1% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.8.
Real-world access to eltrombopag 25 MG Powder for Oral Suspension [Promacta] depends on utilization management as much as tier placement: 100% of covering formularies require prior authorization. 0% require step therapy. 90.9% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 5,708 Part D beneficiaries filled eltrombopag 25 MG Powder for Oral Suspension [Promacta] in 2023, with total plan-and-beneficiary spending of $557,676,106 and an average per-beneficiary annual cost of $97,700.79. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry eltrombopag 25 MG Powder for Oral Suspension [Promacta] today.
Coverage Details
- Formularies covering
- 22
- Plans covering
- 1,016
- Coverage rate
- 20.1%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 5, Specialty
Restrictions
- Prior authorization required
- 100% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 90.9% of formularies
2023 Medicare Spending
- Beneficiaries
- 5,708
- Total spending
- $557,676,106
- Avg per beneficiary
- $97,700.79
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering eltrombopag 25 MG Powder for Oral Suspension [Promacta]
26 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
Show the next 6 plans
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
| Humana Value Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
| Humana Value Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
| Humana Value Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
| Humana Value Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
| Humana Value Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | Yes | No | $0 | - |
Medicare Advantage Plans (MA-PD) Covering eltrombopag 25 MG Powder for Oral Suspension [Promacta]
74 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Hamaspik Medicare Choice (HMO D-SNP) | Hamaspik, Inc. | T1 | Yes | $0 | NY |
| Hamaspik Medicare Select (HMO D-SNP) | Hamaspik, Inc. | T1 | Yes | $34.50 | NY |
| Leon MediExtra (HMO) | Leon Health, Inc. | T4 | Yes | $0 | FL |
| Leon MediDual (HMO D-SNP) | Leon Health, Inc. | T4 | Yes | $0 | FL |
| Leon MediMore (HMO) | Leon Health, Inc. | T4 | Yes | $0 | FL |
| Leon MediMax (HMO D-SNP) | Leon Health, Inc. | T4 | Yes | $0 | FL |
| Medicare BlueEssential (PPO) | Excellus Health Plan, Inc. | T5 | Yes | $0 | NY |
| Medicare BlueActive (PPO) | Excellus Health Plan, Inc. | T5 | Yes | $0 | NY |
| Medicare BlueVital (PPO) | Excellus Health Plan, Inc. | T5 | Yes | $0 | NY |
| Univera SeniorChoice Basic (HMO) | Excellus Health Plan, Inc. | T5 | Yes | $0 | NY |
| Univera SeniorChoice Extra (HMO) | Excellus Health Plan, Inc. | T5 | Yes | $0 | NY |
| Medicare Blue Choice Core (HMO) | Excellus Health Plan, Inc. | T5 | Yes | $0 | NY |
| Univera Medicare Dual (HMO D-SNP) | Excellus Health Plan Community Care LLC | T5 | Yes | $0 | NY |
| Medicare Blue Dual (HMO D-SNP) | Excellus Health Plan Community Care LLC | T5 | Yes | $0 | NY |
| Health New England Medicare Compass (PPO) | Health NEW England, Inc. | T5 | Yes | $0 | MA |
| Health New England Medicare Value (HMO) | Health NEW England, Inc. | T5 | Yes | $0 | MA |
| MCS Classicare RxMax (HMO) | MCS Advantage, Inc. | T5 | Yes | $0 | PR |
| MCS Classicare Platino Ideal (HMO D-SNP) | MCS Advantage, Inc. | T5 | Yes | $0 | PR |
| MCS Classicare Efectivo (HMO) | MCS Advantage, Inc. | T5 | Yes | $0 | PR |
| MCS Classicare Essential (HMO-POS) | MCS Advantage, Inc. | T5 | Yes | $0 | PR |
Show the next 30 plans
Showing top 50 of 74 plans.
Frequently Asked Questions
Is eltrombopag 25 MG Powder for Oral Suspension [Promacta] covered by Medicare Part D?
Yes, eltrombopag 25 MG Powder for Oral Suspension [Promacta] is covered by 1,016 Medicare Part D plans (20.1% of all Part D formularies).
What tier is eltrombopag 25 MG Powder for Oral Suspension [Promacta] on Medicare Part D plans?
eltrombopag 25 MG Powder for Oral Suspension [Promacta] averages Tier 4.8 across Part D plans, ranging from Tier 1 to Tier 5.
Does eltrombopag 25 MG Powder for Oral Suspension [Promacta] require prior authorization?
100% of Part D formularies require prior authorization for eltrombopag 25 MG Powder for Oral Suspension [Promacta]. Step therapy: 0%. Quantity limits: 90.9%.
How much does Medicare spend on eltrombopag 25 MG Powder for Oral Suspension [Promacta]?
In 2023, total Medicare Part D spending on eltrombopag 25 MG Powder for Oral Suspension [Promacta] was $557,676,106, covering 5,708 beneficiaries. The average spend per beneficiary was $97,700.79.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- mercaptopurine 20 MG/ML Oral Suspension [Purixan] T4.8
- prednisone 1 MG Delayed Release Oral Tablet T4.8
- selegiline hydrochloride 1.25 MG Disintegrating Oral Tablet [Zelapar] T4.8
- 0.4 ML adalimumab-adbm 100 MG/ML Prefilled Syringe T4.8
- emtricitabine 200 MG / rilpivirine 25 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet [Complera] T4.8
- 0.2 ML adalimumab-adbm 50 MG/ML Prefilled Syringe T4.7
Similar prior-authorization rate
- azathioprine 50 MG Oral Tablet 100% PA
- 0.5 ML hepatitis B surface antigen vaccine 0.04 MG/ML Prefilled Syringe [Heplisav-B] 100% PA
- 0.5 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] 100% PA
- 1 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] 100% PA
- sotagliflozin 200 MG Oral Tablet [Inpefa] 100% PA
- mycophenolate mofetil 250 MG Oral Capsule 100% PA